It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
On 27–29th of September 2022, Wellcome convened an international multi-stakeholder workshop to discuss the use of Correlates of Protection (CoP) to accelerate vaccine development, the hybrid format meeting was attended by 80 delegates including developers, manufacturers, regulators, public health officials and policy-makers from 17 countries, including 7 LMIC’s.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Wellcome, London, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672)
2 Jinja Publishing Ltd, WHO consultant, London, UK (GRID:grid.52788.30)
3 Coalition for Epidemic Preparedness Innovations (CEPI), London, UK (GRID:grid.52788.30)
4 Fred Hutchinson Cancer Center, Vaccine Infectious Disease Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622)
5 University College London, Great Ormond Street Institute of Child Health, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201)
6 International AIDS Vaccine Initiative (IAVI), New York, USA (GRID:grid.420368.b) (ISNI:0000 0000 9939 9066)
7 London School of Hygiene & Tropical Medicine (LSHTM) Keppel Street, London, United Kingdom (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
8 Cité du Djoué, World Health Organization (WHO) - Regional Office for Africa, Brazzaville, Republic of Congo (GRID:grid.463718.f) (ISNI:0000 0004 0639 2906)
9 University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, USA (GRID:grid.411024.2) (ISNI:0000 0001 2175 4264)
10 University of Pennsylvania, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
11 Vital Brasil Avenue, Instituto Butantan1500, São Paulo, Brazil (GRID:grid.25879.31)
12 ALERT Campus, Armauer Hansen Research Institute, Jimma Road, Addis Ababa, Ethiopia (GRID:grid.418720.8) (ISNI:0000 0000 4319 4715)
13 The Circle 66, MSD, Zürich, Switzerland (GRID:grid.474492.8) (ISNI:0000 0004 0513 4606)
14 PATH 2201 Westlake Avenue, Seattle, USA (GRID:grid.415269.d) (ISNI:0000 0000 8940 7771); US FDA, Seattle, USA (GRID:grid.417587.8) (ISNI:0000 0001 2243 3366)